山东步长制药股份有限公司 关于全资子公司完成工商变更登记的公告

Group 1 - The company announced the completion of business registration changes for its wholly-owned subsidiary, Yangling Buchang Pharmaceutical Co., Ltd. [1] - The changes include an updated business scope, which now encompasses traditional Chinese medicine extraction, medical research and development, and solar power technology services [1] - The registered capital of Yangling Buchang is 158 million RMB, and the company was established on August 31, 2010 [1] Group 2 - The company reported that its wholly-owned subsidiary, Baoding Tianhao Pharmaceutical Co., Ltd., has received approval from the Hebei Provincial Drug Administration for changes to its drug production license [3] - The changes include the addition of new production lines and workshops, specifically for soft capsule production and oral solution production lines [4][5] - The production license is valid until July 7, 2030, and the company is authorized to produce various forms of medications, including ointments, tablets, and oral solutions [4][5]